Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|February 19, 2024
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancerPhaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 InhibitionAmanda Truong, Jae Hyuk Yoo, Michael T Scherzer, et al.
Research Square|September 5, 2025
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistanceAllie Grossmann, Junhua Wang, Yinshen Wee, et al.
Oncogene|July 27, 2023
Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasisJackson R Richards, Donghan Shin, Rob Pryor, et al.
Cancer Discovery|May 26, 2012
A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinomaEric A Collisson, Christy L Trejo, Jillian M Silva, et al.
Cancer Cell|June 7, 2016
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal AdenocarcinomaColin W Steele, Saadia A Karim, Joshua D G Leach, et al.
Nature|October 2, 2003
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesisSarah P Thayer, Marina Pasca di Magliano, Patrick W Heiser, et al.
Nature Genetics|April 8, 2015
Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanomaMichael B Mann, Michael A Black, Devin J Jones, et al.
Elife|January 11, 2017
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesisNaoya Sakamoto, Ying Feng, Carmine Stolfi, et al.
Cancer Cell|January 14, 2015
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formationWilliam Damsky, Goran Micevic, Katrina Meeth, et al.
Pageof 13